These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 28270072)

  • 1. Topical Ingenol Mebutate: A New Treatment Modality for Multiple Actinic Keratoses and Field Cancerization.
    Kostovic K; Gulin SJ; Mokos ZB; Ceovic R
    Anticancer Agents Med Chem; 2017; 17(10):1304-1311. PubMed ID: 28270072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis.
    Anderson L; Schmieder GJ; Werschler WP; Tschen EH; Ling MR; Stough DB; Katsamas J
    J Am Acad Dermatol; 2009 Jun; 60(6):934-43. PubMed ID: 19467365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ingenol mebutate: a promising treatment for actinic keratoses and nonmelanoma skin cancers.
    Gupta AK; Paquet M
    J Cutan Med Surg; 2013; 17(3):173-9. PubMed ID: 23673300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive monitoring of subclinical and clinical actinic keratosis of face and scalp under topical treatment with ingenol mebutate gel 150 mcg/g by means of reflectance confocal microscopy and optical coherence tomography: New perspectives and comparison of diagnostic techniques.
    Ruini C; Hartmann D; Bastian M; Ruzicka T; French LE; Berking C; von Braunmühl T
    J Biophotonics; 2019 Jul; 12(7):e201800391. PubMed ID: 30653833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and tolerability of ingenol mebutate in the treatment of actinic keratosis.
    Berman B
    Expert Opin Drug Saf; 2015; 14(12):1969-78. PubMed ID: 26524598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: results of a randomized, double-blind, vehicle-controlled, multicentre, phase IIa study.
    Siller G; Gebauer K; Welburn P; Katsamas J; Ogbourne SM
    Australas J Dermatol; 2009 Feb; 50(1):16-22. PubMed ID: 19178487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic and pharmacodynamic evaluation of ingenol mebutate for the treatment of actinic keratosis.
    Stockfleth E; Bastian M
    Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):911-918. PubMed ID: 30074409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of ingenol mebutate gel for actinic keratosis in patients in a community dermatology practice.
    Bettencourt MS
    J Drugs Dermatol; 2014 Mar; 13(3):269-73. PubMed ID: 24595570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of ingenol mebutate 0.015% gel after cryosurgery of actinic keratosis: 12-month results.
    Berman B; Goldenberg G; Hanke CW; Tyring SK; Werschler WP; Knudsen KM; Larsson T; Swanson N
    J Drugs Dermatol; 2014 Jun; 13(6):741-7. PubMed ID: 24918567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cost-utility analysis of ingenol mebutate gel for the treatment of actinic keratosis: a Scottish perspective.
    Tolley K; Kemmett D; Thybo S; Nasr R; Smethurst H
    Eur J Health Econ; 2016 Apr; 17(3):287-304. PubMed ID: 25795391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Response to Ingenol Mebutate in Patients With Actinic Keratoses.
    Batalla A; Flórez Á; Feal C; Peón G; Abalde MT; Salgado-Boquete L; de la Torre C
    Actas Dermosifiliogr; 2015 Dec; 106(10):e55-61. PubMed ID: 26055975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The European Medicines Agency approval of ingenol mebutate (Picato) for the cutaneous treatment of non-hyperkeratotic, non-hypertrophic actinic keratosis in adults: summary of the scientific assessment of the Committee for Medicinal Products for Human Use (CHMP).
    Tzogani K; Nagercoil N; Hemmings RJ; Samir B; Gardette J; Demolis P; Salmonson T; Pignatti F
    Eur J Dermatol; 2014; 24(4):457-63. PubMed ID: 25115145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Ingenol Mebutate in the Treatment of Actinic Keratoses: A Pre- and Posttreatment Dermoscopic Comparative Analysis.
    Carbotti M; Coppola R; Zanframundo S; Devirgiliis V; Panasiti V
    Biomed Res Int; 2018; 2018():4381019. PubMed ID: 30246021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of facial actinic keratoses with aminolevulinic acid photodynamic therapy (ALA-PDT) or ingenol mebutate 0.015% gel with and without prior treatment with ALA-PDT.
    Berman B; Nestor MS; Newburger J; Park H; Swenson N
    J Drugs Dermatol; 2014 Nov; 13(11):1353-6. PubMed ID: 25607702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ingenol mebutate gel 0.015% and 0.05%: in actinic keratosis.
    Keating GM
    Drugs; 2012 Dec; 72(18):2397-405. PubMed ID: 23231025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial comparing simultaneous vs. sequential field treatment of actinic keratosis with ingenol mebutate on two separate areas of the head and body.
    Pellacani G; Peris K; Guillen C; Clonier F; Larsson T; Venkata R; Puig S
    J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2192-8. PubMed ID: 26300464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the use of ingenol mebutate to prevent non-melanoma skin cancer.
    Erlendsson AM
    Dan Med J; 2017 Nov; 64(11):. PubMed ID: 29115209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up study of ingenol mebutate gel for the treatment of actinic keratoses.
    Lebwohl M; Shumack S; Stein Gold L; Melgaard A; Larsson T; Tyring SK
    JAMA Dermatol; 2013 Jun; 149(6):666-70. PubMed ID: 23553119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy, safety and tolerability of field treatment of actinic keratosis with ingenol mebutate 0.015 % gel: a single center case series.
    Bobyr I; Campanati A; Consales V; Giuliodori K; Scalise A; Offidani A
    Springerplus; 2016; 5():627. PubMed ID: 27330893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ingenol mebutate gel for actinic keratosis.
    Lebwohl M; Swanson N; Anderson LL; Melgaard A; Xu Z; Berman B
    N Engl J Med; 2012 Mar; 366(11):1010-9. PubMed ID: 22417254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.